Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top 5 worldwide oncology products by market share 2017 and 2024

Top 5 oncology products worldwide by market share in 2017 and 2024

by Matej Mikulic, last edited Jun 19, 2019
Top 5 worldwide oncology products by market share 2017 and 2024 This statistic displays the top oncology products worldwide by projected market share for 2024, and their market shares in 2017. Cancer drug Opdivo from Bristol-Myers Squibb and Ono Pharmaceutical is expected to keep its position with a market share of five percent.
Top oncology products

Oncological products generate a significant proportion of their revenue in the United States and in Europe. In 2012, oncology spending totaled nearly 50 billion U.S. dollars in the United States and 22 billion U.S. dollars in the leading five EU-countries. Oncology is among the top therapy classes in the pharmaceutical market.

Among the top oncology products in 2017 were Keytruda and Opdivo, generating 3.8 and 5.7 billion U.S. dollars on the worldwide market. Top cancer drug Rituxan is marketed by Roche and is used to treat diseases such as lymphomas, leukemias, transplant rejections, and autoimmune disorders. Bevacizumab, marketed as Avastin also under Roche, is used to slow down the growth rate of new blood vessels. It can be used to treat cancers such as those originating in the colorectum, lung, breast, or kidney. Roche has a stronghold on the global oncology market. In 2017, Roche maintained a share of over 26 percent of the market but is expected to drop to some 12 percent of the market in 2024. Roche or Hoffman-La Roche is a Swiss company that was founded in 1896. The company focuses primarily on pharmaceutical products and diagnostics. Roche generated more than 53 billion Swiss francs in revenue in 2017, making it one of the most successful biotech and pharmaceutical companies in the world.
Show more

Top 5 oncology products worldwide by market share in 2017 and 2024

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format

All Information
in one Presentation


Everything On "Oncology" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Oncology"
  • Cancer facts
  • Oncology market
  • Companies
  • Cancer drugs
The most important statistics
  • Research and development
  • Immuno-oncology
  • Treatment types
  • Physicians and patients
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.